T-ACE Medical Co., Ltd., founded in 2018 with support from Taiwan's Value Creation Program for University Start-up Teams, is led by Dr. Xi-Zhang Lin of National Cheng Kung University Hospital (NCKUH). Backed by a cross-disciplinary alliance among NCKU, the Industrial Technology Research Institute (ITRI), and the Food Industry Research and Development Institute (FIRDI), we focus on advancing medical solutions for the hepatobiliary, gastrointestinal, and digestive systems — showcasing the strength of Taiwan’s clinical innovation. Guided by unmet clinical needs observed at the bedside, we transform real-world medical challenges into innovative, cost-effective solutions that improve care quality and patient outcomes.